FGP
INSP icon

Freestone Grove Partners’s Inspire Medical Systems INSP Stock Holding History

Freestone Grove Partners’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Buy
7,811
+4,790
+159% +$227K ﹤0.01% 727
2026
Q1 		$156K Buy
+3,021
New +$211K ﹤0.01% 762
2025
Q4 		– Sell
-8,676
Closed -$644K – 822
2025
Q3 		$644K Buy
+8,676
New +$878K ﹤0.01% 499

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Freestone Grove Partners's INSP Position: Q2 2026 in Review

Freestone Grove Partners increased its Inspire Medical Systems (INSP) stake by 159% in Q2 2026, buying an estimated $227K and bringing the position to 7,811 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #727.

Freestone Grove Partners first reported a position in INSP in Q3 2025 and has held it in 3 quarters since. The position peaked at $644K in Q3 2025. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Freestone Grove Partners held 7,811 shares of Inspire Medical Systems worth $348K as of Q2 2026.
  • Freestone Grove Partners bought 4,790 Inspire Medical Systems shares in Q2 2026, an estimated $227K.
  • Inspire Medical Systems made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #727 holding.
  • Freestone Grove Partners first reported a position in Inspire Medical Systems in Q3 2025 and has held it in 3 quarters since.
  • Freestone Grove Partners's Inspire Medical Systems position peaked at $644K in Q3 2025.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.